Healthcare Innovation August 28, 2024
Oncology Ventures’ fund is backed by several institutions, including Cardinal Health, City of Hope, and Moffitt Cancer Center
Venture capital fund Oncology Ventures announced the close of an oversubscribed $30 million Fund I to invest in data-driven startups improving cancer care and research.
New York-based Oncology Ventures is led by Ben Freeberg, a healthcare investor who previously served as vice president at Optum Ventures and was the first hire at Alpha Partners. Freeberg said his operational experience at cancer startup Thyme Care and his personal experience as a cancer survivor position him well to invest in and empower the next generation of cancer startups.
“Cancer care today is prohibitively expensive and overly complex. We will invest in cutting-edge data...
Today's Sponsors
Today's Sponsor